IOL Chemicals & Pharmaceuticals Ltd
IOL Chemicals & Pharmaceuticals Ltd (IOLCP) last traded at ₹172, a market capitalisation of ₹5,046 crore, on a P/E of 28.6. Over the past 52 weeks the stock has ranged between ₹67.1 and ₹180. IOL Chemicals & Pharmaceuticals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹756 crore and net profit of ₹64 crore. IOL Chemicals & Pharmaceuticals Ltd’s annual general meeting is scheduled for 2 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
IOL Chemicals & Pharmaceuticals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
IOL Chemicals & Pharmaceuticals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹756 cr, up 37.0% from ₹552 cr a year earlier. Net profit was ₹64 cr, up 88.2% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 526 | 523 | 528 | 552 | 568 | 580 | 619 | 756 |
| Expenses | 484 | 476 | 465 | 490 | 510 | 523 | 527 | 653 |
| Operating profit | 42 | 47 | 63 | 62 | 57 | 57 | 92 | 103 |
| OPM % | 8% | 9% | 12% | 11% | 10% | 10% | 15% | 14% |
| Other income | 6 | 4 | 5 | 7 | 7 | -6 | 2 | 8 |
| Interest | 4 | 4 | 4 | 4 | 3 | 4 | 3 | 4 |
| Depreciation | 18 | 19 | 19 | 20 | 20 | 20 | 20 | 21 |
| Profit before tax | 26 | 28 | 45 | 46 | 40 | 28 | 71 | 87 |
| Tax % | 26% | 26% | 30% | 25% | 26% | 25% | 25% | 26% |
| Net profit | 19 | 21 | 31 | 34 | 30 | 21 | 53 | 64 |
| EPS (₹) | 0.65 | 0.70 | 1.07 | 1.16 | 1.02 | 0.70 | 1.81 | 2.19 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
IOL Chemicals & Pharmaceuticals Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 2,184 | 2,217 | 2,133 | 2,079 | 2,319 | 2,524 |
| Operating profit | 259 | 226 | 231 | 202 | 270 | 310 |
| OPM % | 12% | 10% | 11% | 10% | 12% | 12% |
| Net profit | 168 | 139 | 134 | 101 | 138 | 168 |
| EPS (₹) | 5.71 | 4.74 | 4.58 | 3.44 | 4.69 | 5.72 |
TTM is the trailing twelve months to the most recent quarter.
IOL Chemicals & Pharmaceuticals Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 2%
- TTM
- 19%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 2%
- TTM
- 68%
- 10 Years
- 20%
- 5 Years
- 9%
- 3 Years
- 31%
- 1 Year
- 79%
- 10 Years
- %
- 5 Years
- 9%
- 3 Years
- 8%
- Last Year
- 8%
IOL Chemicals & Pharmaceuticals Ltd shareholding pattern
Promoters held 62.28% at Jun 2026, up from 52.62% at Jun 2025. FIIs 4.87% and DIIs 0.43%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 48.19% | 52.62% | 52.62% | 52.62% | 52.62% | 52.62% | 57.48% | 62.28% |
| FIIs | 1.63% | 1.49% | 1.47% | 2.59% | 2.25% | 2.08% | 1.72% | 4.87% |
| DIIs | 0.07% | 0.08% | 0.07% | 0.02% | 0.05% | 0.03% | 0.02% | 0.43% |
| Public | 50.11% | 45.81% | 45.84% | 44.76% | 45.10% | 45.26% | 40.78% | 32.41% |
| No. of shareholders | 1,25,979 | 1,26,701 | 1,30,002 | 1,25,040 | 1,36,129 | 1,33,531 | 1,31,550 | 1,19,311 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Cruxal coverage of IOL Chemicals & Pharmaceuticals Ltd
When is IOL Chemicals & Pharmaceuticals Ltd’s AGM?
IOL Chemicals & Pharmaceuticals Ltd’s annual general meeting is scheduled for 2 Sept 2026.
- AGM39th Annual General Meeting to adopt financial statements, re-appoint a director, and ratify cost auditor remuneration
See the full results calendar for every Indian company reporting in the next 30 days.
IOL Chemicals & Pharmaceuticals Ltd corporate filings
- Earning Call TranscriptCompany Updatehigh impact
Cruxal's analysis: IOL Chemicals and Pharmaceuticals Limited delivered a robust Q1 FY27, reporting revenue…
Read the full analysis - Submission of Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: IOL Chemicals & Pharmaceuticals Ltd has submitted the mandatory newspaper publication…
Read the full analysis - Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1- FY2027Company Updatelow impact
Cruxal's analysis: IOL Chemicals and Pharmaceuticals Limited has filed the audio recording of its analyst…
Read the full analysis - Investor PresentationCompany Updatehigh impact
Cruxal's analysis: IOL Chemicals and Pharmaceuticals Limited delivered robust Q1 FY27 results, with revenue…
Read the full analysis - Communication to the Shareholders regarding AGM Notice ansd Annual Report for the Financial Year 2025-26Company Updatelow impact
Cruxal's analysis: IOL Chemicals and Pharmaceuticals Limited has announced that its 39th Annual General…
Read the full analysis - Submission of newspaper publication of unaudited Financial Results for the quarter ended 30th June 2026Company Updatehigh impact
Cruxal's analysis: IOL Chemicals and Pharmaceuticals Limited reported robust financial results for the…
Read the full analysis - Press Release- Financial Results for the quarter ended 30th June 2026Company Updatehigh impact
Cruxal's analysis: IOL Chemicals and Pharmaceuticals Limited delivered a strong Q1 FY27 performance…
Read the full analysis - Outcome of the Board Meeting and submission of Unaudited Financial Results of the Company for the quarter ended 30th June 2026Board Meetinghigh impact
Cruxal's analysis: IOL Chemicals and Pharmaceuticals Limited reported robust financial results for the…
Read the full analysis - Copy of notice published in NewspapersCompany Updatelow impact
Cruxal's analysis: IOL Chemicals & Pharmaceuticals Ltd has published a notice in newspapers in compliance…
Read the full analysis - Schedule of analyst / investor conference call - Q1 FY27Company Updatelow impact
Cruxal's analysis: IOL Chemicals & Pharmaceuticals has announced a conference call for investors and…
Read the full analysis - Submission of BRSR FY 2025-26Otherslow impact
Cruxal's analysis: IOL Chemicals & Pharmaceuticals has filed its Business Responsibility and Sustainability…
Read the full analysis - Notice of 39th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: IOL Chemicals and Pharmaceuticals Limited has issued the formal notice for its 39th…
Read the full analysis - Submission of Integrated Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: IOL Chemicals & Pharmaceuticals Ltd has filed its Integrated Annual Report for the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track IOL Chemicals & Pharmaceuticals Ltd
Cruxal reads every IOL Chemicals & Pharmaceuticals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.